Dezhan Healthcare Company Limited

SZSE:000813 Stock Report

Market Cap: CN¥7.1b

Dezhan Healthcare Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Dezhan Healthcare.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth19.0%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Dezhan Healthcare's (SZSE:000813) Shareholders May Want To Dig Deeper Than Statutory Profit

Nov 06
Dezhan Healthcare's (SZSE:000813) Shareholders May Want To Dig Deeper Than Statutory Profit

Dezhan Healthcare Company Limited's (SZSE:000813) Share Price Could Signal Some Risk

Oct 25
Dezhan Healthcare Company Limited's (SZSE:000813) Share Price Could Signal Some Risk

We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

Apr 18
We Like The Quality Of Dezhan Healthcare's (SZSE:000813) Earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dezhan Healthcare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:000813 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/202451730-126-9N/A
6/30/2024526101-9067N/A
3/31/202446465-66101N/A
12/31/202349883-32128N/A
9/30/2023489-52-3160N/A
6/30/2023488-12042117N/A
3/31/2023513-761681N/A
1/1/2023571-4794162N/A
9/30/2022638-116-7830N/A
6/30/2022647-95-139-19N/A
3/31/2022716-91-10219N/A
1/1/2022734-58-8542N/A
9/30/202163717061156N/A
6/30/2021640205104231N/A
3/31/2021704257402526N/A
12/31/2020963285717828N/A
9/30/20201,209238818923N/A
6/30/20201,5682771,4741,534N/A
3/31/20201,7643081,5741,629N/A
12/31/20191,7753371,4941,559N/A
9/30/20192,0485391,5461,587N/A
6/30/20192,5527299731,021N/A
3/31/20192,984873715765N/A
12/31/20183,291931311380N/A
9/30/20183,50589495192N/A
6/30/20183,086814N/A235N/A
3/31/20182,658812N/A354N/A
12/31/20172,220797N/A385N/A
9/30/20171,750775N/A374N/A
6/30/20171,585765N/A384N/A
3/31/20171,485694N/A204N/A
12/31/20161,443662N/A262N/A
12/31/20151,179509N/A106N/A
12/31/2014995355N/A192N/A
9/30/2014895279N/A201N/A
6/30/2014860251N/A178N/A
3/31/2014981235N/A104N/A
12/31/20131,038170N/A61N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 000813's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 000813's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 000813's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 000813's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 000813's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 000813's Return on Equity is forecast to be high in 3 years time


Discover growth companies